Aiman Shalabi

Aiman Shalabi

Company: GSK

Job title: VP, Medicines Development Leader, Cell and Gene Therapies


Correlative Analysis to Assess Modulation to the Tumor Microenvironment 10:00 am

Review biopsy material pre and post treatment to analyse the changes in the tumor microenvironment caused by the cell therapy Outline trafficking activity of the cells to the tumor site and understand if they are functioning when in the TME Assessing efficacy and safety dataRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.